Epstein Secrets

inue to like TEVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a

g end and weakness in US equities is unusual of late and t=lls us there is implications for risk parity portfolios. =/p> We expect a 165k change in Non-Farm Pay=olls on Friday but a strong number sets up for some left hand tail risk in US Fixed Income. Risk parity portfolios own more bonds t=an equities (du

inue to like TEVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a

g end and weakness in US equities is unusual of late and t=lls us there is implications for risk parity portfolios. =/p> We expect a 165k change in Non-Farm Pay=olls on Friday but a strong number sets up for some left hand tail risk in US Fixed Income. Risk parity portfolios own more bonds t=an equities (du

nue to like TEVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a

g end and weakness in US equities is unusual of late and t=lls us there is implications for risk parity portfolios. =/p> We expect a 165k change in Non-Farm Pay=olls on Friday but a strong number sets up for some left hand tail risk in US Fixed Income. Risk parity portfolios own more bonds t=an equities (du